Shionogi Joins the World Economic Forum and Signs the Davos Compact on Antimicrobial Resistance — Contributing to the Resolution of Global Healthcare Challenges, Including AMR, Through International Collaboration

Shionogi & Co., Ltd. today announced that it joined the World Economic Forum on April 1, 2026, and signed the Davos Compact on Antimicrobial Resistance (AMR) on April 28, 2026. The World Economic Forum, established in 1971 and headquartered in Switzerland, is an independent international organization committed to improving the state of the world. It engages leaders from business, government, academia, and civil society to shape global, regional, and industry agendas. The Forum provides platforms for dialogue on critical global issues, including through its Annual Meeting in Davos and various public-private partnership initiatives across sectors.